EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Fibrinogen at Recurrence as a Prognostic Blood Biomarker in Oral Cavity Squamous Cell Carcinoma

Rafael Gómez-Fernández iD, Jorge Vallejo-Díez, Beatriz Zarauza-Santos, Belén Burgos-Vico iD, Sonia de Las Heras-Losada, Luis Miguel Redondo-González

Diagnostics · 21.07.2026 · 16 (14) · 2276

DOI: 10.3390/diagnostics16142276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 21.07.2026. Verfasst von Rafael Gómez-Fernández und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Hospital Universitario Río Hortega, Calle Dulzaina 2, 47012 Valladolid, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HURH–ICSCYL (Hospital Universitario Río Hortega—Instituto de Estudios de Ciencias de la Salud de Castilla y León.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preoperative inflammatory biomarkers, particularly the neutrophil-to-lymphocyte ratio (NLR), are established prognostic markers in oral cavity squamous cell carcinoma (OCSCC), yet their relevance at the biologically distinct timepoint of disease recurrence is unknown. We evaluated blood biomarkers measured at recurrence.

Methods

From a retrospective cohort of 168 surgically treated OCSCC patients, 70 (41.7%) developed recurrence (49 local, 21 distant). NLR, lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), plasma fibrinogen, albumin and the prognostic nutritional index (PNI) at relapse were analysed against 5-year overall survival; multivariate logistic regression was adjusted for age and recurrence type.

Results

Forty-nine of 70 patients (70.0%) died within 5 years. Fibrinogen was higher in deceased patients (median 595 vs. 464 mg/dL; p = 0.007) and was the only biomarker to retain independent significance (OR 1.005 per mg/dL; 95% CI 1.000–1.010; p = 0.038); in contrast, NLR lost significance (p = 0.156). LMR was significant univariately (p = 0.036); PLR, albumin and PNI were not.

Conclusions

In this exploratory single-centre cohort, higher plasma fibrinogen at recurrence was independently associated with 5-year mortality, whereas inflammatory ratios were not. These hypothesis-generating findings warrant validation in larger, multicentre cohorts.

Schlagwörter

Stichwörter der Autor:innen

fibrinogenoral squamous cell carcinomaprognostic biomarkersrecurrence

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Hospital Universitario Río Hortega, Calle Dulzaina 2, 47012 Valladolid, Spain.

ORCID-Profile: Rafael Gómez-Fernández, Belén Burgos-Vico

Förderung

  • HURH–ICSCYL (Hospital Universitario Río Hortega—Instituto de Estudios de Ciencias de la Salud de Castilla y León

Zitieren

APA

Gómez-Fernández, R., Vallejo-Díez, J., Zarauza-Santos, B., Burgos-Vico, B., Heras-Losada, S. L., & Redondo-González, L. M. (2026). Plasma Fibrinogen at Recurrence as a Prognostic Blood Biomarker in Oral Cavity Squamous Cell Carcinoma. Diagnostics, 16(14), 2276. https://doi.org/10.3390/diagnostics16142276

Vancouver

Gómez-Fernández R, Vallejo-Díez J, Zarauza-Santos B, Burgos-Vico B, Heras-Losada SL, Redondo-González LM. Plasma Fibrinogen at Recurrence as a Prognostic Blood Biomarker in Oral Cavity Squamous Cell Carcinoma. Diagnostics. 2026;16(14):2276. doi:10.3390/diagnostics16142276

BibTeX
@article{GmezFernndez2026,
  author = {Gómez-Fernández, Rafael and Vallejo-Díez, Jorge and Zarauza-Santos, Beatriz and Burgos-Vico, Belén and Heras-Losada, Sonia de Las and Redondo-González, Luis Miguel},
  title = {Plasma Fibrinogen at Recurrence as a Prognostic Blood Biomarker in Oral Cavity Squamous Cell Carcinoma},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {14},
  pages = {2276},
  doi = {10.3390/diagnostics16142276}
}
Kostenlos starten →